Rabies Vaccine Protocol for Previously Vaccinated Individuals

Definition and Protocol

• Previously vaccinated individuals, as defined by the Centers for Disease Control and Prevention, who have received one of the recommended preexposure or postexposure regimens of HDCV, PCECV, or RVA, or have a documented rabies virus neutralizing antibody titer, should receive two intramuscular doses of rabies vaccine, one immediately and one 3 days later, without rabies immunoglobulin 1, 2, 3
• The Centers for Disease Control and Prevention recommends that previously vaccinated individuals receive two IM doses (1.0 mL each) in the deltoid muscle, with the first dose administered immediately upon presentation and the second dose 3 days after the first dose 1, 2, 3

Postexposure Management

• The American Academy of Pediatrics and the Centers for Disease Control and Prevention suggest that previously vaccinated individuals do not require rabies immunoglobulin, as it may inhibit the strength or rapidity of the expected anamnestic immune response 1, 3, 4
• Previously vaccinated individuals develop a rapid anamnestic antibody response following booster vaccination, regardless of their pre-booster antibody titer, which eliminates the need for rabies immunoglobulin and the full vaccination series 3, 5, 6

Special Considerations

• The Centers for Disease Control and Prevention advises that immunosuppressed individuals may have suboptimal response to vaccination and require special consideration, including consultation with public health officials if treating an immunosuppressed previously vaccinated individual 1, 4
• Determining the rabies virus neutralizing antibody titer before administering boosters to previously vaccinated persons exposed to rabies is unnecessary and inappropriate, as it would delay treatment and no specific "protective" titer is definitively established 2, 3, 6

Rabies Vaccination Guidelines for Previously Vaccinated Individuals

Post-Exposure Protocol

• The Centers for Disease Control and Prevention recommends that previously vaccinated individuals with a complete rabies vaccine series and exposed to rabies 2 years later, receive 2 booster doses (on days 0 and 3) with 1.0 mL intramuscular (deltoid muscle) immediately upon exposure and 1.0 mL intramuscular 3 days after the first dose, without the need for rabies immunoglobulin (RIG) 7
• Previously vaccinated individuals are considered "previously vaccinated" if they completed a recommended pre-exposure vaccination series (3 doses) with HDCV, PCECV, or RVA, and can receive a simplified 2-dose regimen consisting of 1.0 mL intramuscular (deltoid muscle) immediately upon exposure and 1.0 mL intramuscular 3 days after the first dose 7

Booster Dose Recommendations

• The American College of Physicians recommends that routine booster doses are NOT required for most previously vaccinated individuals after 2 years, but boosters are only recommended for high-risk groups, such as lab workers handling live rabies virus, veterinarians, animal control officers, and spelunkers, who should check antibody titers every 2 years or give booster without testing 7
• The Centers for Disease Control and Prevention recommends that individuals with frequent risk, such as veterinarians, animal control officers, and spelunkers, should check titers every 2 years or give booster without testing, while those with infrequent risk, such as general veterinarians in low-risk areas and travelers, do not need routine boosters 7

Intradermal vs Intramuscular Rabies PEP for Previously Vaccinated Patients

Regulatory Context and Guidelines

• The World Health Organization (WHO) and the Advisory Committee on Immunization Practices (ACIP) recognize the Thai Red Cross intradermal (ID) schedule as an efficacious alternative to the intramuscular (IM) regimen for previously vaccinated individuals 8, 9
• The ACIP.Ptr ACIP recommends 2 doses of 1.0 mL IM (deltoid) on days 0 and 3 for previously vaccinated individuals, without rabies immunoglobulin, as the FDA-approved protocol in the United States 10
• The Centers for Disease Control and Prevention (CDC) and ACIP define previously vaccinated persons as those who completed a recommended pre-exposure or post-exposure series with cell-culture vaccines or have documented adequate antibody response 10

ID Regimen Details and Evidence

• The Thai Red Cross ID schedule uses 0.1 mL ID doses at two sites on days 0, 3, and 7, followed by single 0.1 mL boosters on days 30 and 90, and is recognized as effective by WHO and ACIP 8, 9
• The ID regimen offers significant cost savings without compromising protection, using 1/10th the vaccine volume of the IM regimen 8, 9
• The ID schedules have not been submitted for FDA approval in the United States but are recognized as effective alternatives in rabies-endemic countries 11, 8, 9

Administration and Special Considerations

• Vaccine must never be administered in the gluteal area, as this produces inadequate antibody responses, and should be given in the deltoid muscle (IM) or deltoid area (ID) for adults, and anterolateral thigh for young children 11, 10
• Previously vaccinated individuals should NOT receive rabies immunoglobulin, as it inhibits the anamnestic immune response 10

Post‑Exposure Rabies Management for Previously Vaccinated Individuals

Rabies Immune Globulin (RIG) Recommendation

• The Centers for Disease Control and Prevention (CDC) advises that persons who have previously completed a full pre‑exposure or post‑exposure rabies vaccination series should not receive rabies immune globulin after a new exposure, because RIG can interfere with the rapid anamnestic antibody response that these individuals are able to mount. 12

Wound‑Care Recommendations

• The CDC recommends immediate and thorough cleansing of all bite or scratch wounds with soap and water, a simple measure that markedly lowers the risk of rabies transmission after exposure. 12
• The CDC advises avoiding suturing of rabies‑exposed wounds whenever feasible, as suturing can trap virus particles and impede wound cleaning. 12

Evidence of Efficacy for the Simplified Booster Regimen

• The CDC reports that no documented rabies failures have occurred when appropriate modern rabies biologics (vaccines and, when indicated, RIG) have been administered to individuals previously vaccinated, supporting the safety of the abbreviated booster schedule. 12

Post‑Exposure Rabies Prophylaxis for Previously Vaccinated Individuals

Booster Vaccine Regimen

• The Advisory Committee on Immunization Practices (ACIP) recommends that a previously vaccinated person who sustains a Category III exposure receive two 1.0 mL intramuscular doses of rabies vaccine—the first dose immediately (day 0) and the second dose on day 3—without rabies immunoglobulin (RIG). [13][14]15
• Because these individuals are already immunologically primed, a two‑dose booster replaces the full five‑dose series used for unvaccinated patients. 13

Rabies Immunoglobulin (RIG) Recommendations

• RIG should not be administered to previously vaccinated persons; passive antibody can blunt the rapid anamnestic response that provides protection. [13][14]
• RIG is indicated only for persons who have never received rabies vaccination (pre‑ or post‑exposure). 16

Vaccine Administration Technique

• Each 1.0 mL dose is given intramuscularly in the deltoid muscle of the adult patient. The first dose is given at presentation (day 0) and the second dose three days later (day 3). [13][14]
• For young children, the anterolateral thigh is an acceptable alternative injection site. 16

Wound Management

• Immediate, thorough wound cleansing with soap and water for approximately 15 minutes should be performed before or concurrently with vaccination. 16
• When available, a virucidal agent such as povidone‑iodine should be applied after washing. 16
• Animal‑model studies have shown that thorough wound cleansing markedly reduces the likelihood of rabies transmission. 16
• Tetanus prophylaxis and appropriate antibacterial measures should be given as indicated. 16

Serologic Testing and Timing

• Do not delay the booster regimen to obtain pre‑booster antibody titers; waiting several days can create dangerous treatment delays. 13
• No definitive “protective” titer threshold has been established for making treatment decisions. 13
• Because immunity to rabies involves more than antibodies alone, the two‑dose booster is recommended regardless of pre‑booster antibody levels. [14][15]

Evidence of Immunologic Memory

• Studies cited by ACIP show that 93–98 % of individuals who completed the three‑dose pre‑exposure series retain complete virus neutralization (≥1:5 dilution) two years after vaccination. 13
• In the United States, no documented treatment failures have occurred when modern rabies biologics were administered appropriately to previously vaccinated persons. 17

Public Health Consultation

• If seroconversion fails after completing the booster series, clinicians should consult public health officials for further guidance. 13

Common Pitfalls to Avoid

• Do not give RIG to a previously vaccinated patient (most critical error). [13][14]
• Do not postpone vaccination while awaiting antibody test results. 13
• Do not inject the vaccine into the gluteal muscle; this site yields inadequate antibody responses. (Supported by ACIP practice guidance, though not directly cited here).
• Do not neglect wound care; immediate thorough cleansing is as essential as the vaccine itself. 16